Competitive Technologies attempts to corner homocysteine testing market through its broad patent
This article was originally published in Clinica
Executive Summary
Diagnostics companies that offer a homocysteine test as a cardiac marker have reacted with surprise to the claims of one US patent commercialisation company, which says it has a broad patent on the application of homocysteine in such tests.